ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 9 of 30 for:    fop

An Open-Label Extension Study of Palovarotene to Prevent Heterotopic Ossification in FOP Subjects in France

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02979769
Recruitment Status : Active, not recruiting
First Posted : December 2, 2016
Last Update Posted : February 14, 2018
Sponsor:
Information provided by (Responsible Party):
Clementia Pharmaceuticals Inc.